Loading...
R&D tax credits can be a vital source of support for medtech companies, helping to offset the costs of developing innovative technologies and bringing new solutions to market.
However, recent turbulence, including increased HMRC scrutiny, new compliance requirements and legislative changes, has made the landscape more complex to navigate.
At LimestoneGrey, we work closely with our clients to guide them through this evolving landscape, ensuring they meet HMRC’s requirements and prepare robust, compliant claims.
Our approach is hands-on and collaborative, giving companies the confidence to access the relief correctly while maintaining focus on their innovation and growth.
